14 completed, 3 not yet recruiting, 3 withdrawn, 2 active not recruiting. 26 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 26 | Completed 14, Not yet recruiting 3, Withdrawn 3, Active not recruiting 2, Terminated 2, Unknown 2 |
Follow Pediatric Obesity: new trials by email Literature Review of Pediatric Obesity trials Research Report on Pediatric Obesity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Community Active and Healthy Families Pragmatic Trial Community Active and Healthy Families Intensive Health Behavior and Lifestyle Treatment - Child Obesity | Phase 4 | Not yet recruiting | University of Colorado, Denver | 416 | 2028-01-01 | 2026-10-09 |
| GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward Semaglutide - Obesity, Childhood | Phase 4 | Not yet recruiting | University of Minnesota | 1020 | 2026-11-15 | 2026-10-20 |
| Treating Toddler Obesity by Treating the Parent/Caregiver Obesity With Weight Loss Medications Lomaira 8Mg Tablet - Weight Loss, Obesity, Childhood | Phase 4 | Withdrawn | Loma Linda University | 2025-12-01 | 2025-11-20 | |
| Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone Liraglutide daily (0.6-3.0mg, highest tolerable dose) additional to dietological measures and lifestyle optimization suggestions, Dietologic measures and lifestyle optimization for weight loss - Obesity, Adolescent | Phase 4 | Not yet recruiting | Medical University of Vienna | 72 | 2025-05-01 | 2025-03-21 |
| Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml - Severe Obesity, Cardiovascular Function | Phase 4 | Active not recruiting | University of Sao Paulo General Hospital | 30 | 2024-03-30 | 2026-05-15 |
| Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes Control, Albuterol - Asthma in Children, Dyspnea; Asthmatic | Phase 4 | Withdrawn | Ohio State University | 2023-07-01 | 2023-11-07 | |
| Young Adults With Early-onset Obesity Treated With Semaglutide TCOC treatment, Semaglutide 3 mg/ml, Placebo (Semaglutide 3 mg/ml) - Obesity, Adolescent | Phase 4 | Completed | Signe Torekov | 246 | 2022-05-30 | 2026-07-08 |
| Effect of Polysaccharide-based Complex Administration on the Gut Microbiome and Cardio-Metabolic Profile in Children With Obesity and Metabolic Syndrome. Polysaccharide-based complex - Childhood Obesity | Phase 4 | Completed | University of Milan | 36 | 2022-02-01 | 2026-01-06 |
| Surgical or Medical Treatment Advanced Medical Therapy and Bariatric Surgery, Advanced Medical Therapy, Bariatric Surgery - Diabetes Mellitus, Type 2, Pediatric Obesity | Phase 4 | Active not recruiting | Children's Hospital Medical Center, Cincinnati | 88 | 2019-12-15 | 2026-03-24 |
| Effectiveness of Antidiabetic Treatment Applied in Childhood Obesity Metformin - Childhood Obesity, Insulin Resistance | Phase 4 | Completed | HÜMEYRA ACIKAN | 52 | 2019-11-17 | 2024-02-20 |
| A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity VI-0521 oral capsule, Placebo oral capsule, Lifestyle Modification - Adolescent Obesity, Obesity in Adolescence | Phase 4 | Completed | VIVUS LLC | 223 | 2019-05-02 | 2022-09-10 |
| Effect of POSTbiotics Supplementation on Microbiome in OBese Children: the POST-OB Study Vitamin D3, Immunofos, Promotion of physical activity - Childhood Obesity | Phase 4 | Unknown | University of Milan | 30 | 2019-01-07 | 2020-07-28 |
| Effect of Docosahexaenoic Acid Supplementation on Microbiome in Obese ChiLdrEn. Docosahexaenoic Acid Supplementation, Promotion of physical activity, Promotion of healthy food habits - Childhood Obesity | Phase 4 | Unknown | University of Milan | 30 | 2019-01-07 | 2020-11-03 |
| Lactoferrin Versus Iron Supplement in Irondeficiency Anemia and Weight Loss in Obese Children Iron Supplement - Obesity, Childhood | Phase 4 | Completed | Ain Shams University | 50 | 2018-10-01 | 2019-07-10 |
| Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity Albuterol Sulfate, Interval Warm-up exercise - Asthma in Children, Obesity, Childhood | Phase 4 | Terminated | University of Nevada, Las Vegas | 34 | 2018-09-18 | 2021-07-22 |
| Effect of Obesity on Proton Pump Inhibitors Lansoprazole, Pantoprazole, Midazolam - Pediatric Obesity, NAFLD | Phase 4 | Completed | Children's Mercy Hospital Kansas City | 76 | 2018-07-03 | 2026-06-04 |
| ZIMBA: Clinical Trial in Paediatric Obesity Zinc, Placebos, Myoinositol - Obesity, Childhood, Insulin Resistance | Phase 4 | Completed | Azienda Ospedaliero Universitaria Maggiore della Carita | 56 | 2018-02-05 | 2024-08-09 |
| Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia Vitamin E 400 UNT, Placebo oral capsule - Obesity, Adolescent, Oxidative Stress | Phase 4 | Completed | Universitas Indonesia | 69 | 2017-09-28 | 2018-03-02 |
| A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents Placebo, VI-0521 Mid Dose, VI-0521 Top Dose - Pediatric Obesity, Childhood Obesity | Phase 4 | Completed | VIVUS LLC | 42 | 2016-03-01 | 2022-08-23 |
| Use of Metformin in Treatment of Childhood Obesity Metformin, Placebo - Pediatric Obesity | Phase 4 | Completed | University of Colombo | 339 | 2014-07-01 | 2017-01-02 |
Showing 20 of 26. Sign in to see all of them.
Obesity (7) · Insulin Resistance (6) · Weight Loss (4) · Diabetes Mellitus, Type 2 (3) · Cardiovascular Diseases (2) · Glucose Intolerance (2) · Motor Activity (2) · Asthma (1) · Asthma, Exercise-Induced (1) · Dyspnea (1) · Fatty Liver (1) · Gastroesophageal Reflux (1) · Hyperinsulinism (1) · Metabolic Syndrome (1)
Body Weight (26) · Nutrition Disorders (26) · Nutritional and Metabolic Diseases (26) · Overnutrition (26) · Overweight (26) · Pathological Conditions, Signs and Symptoms (26) · Signs and Symptoms (26) · Obesity (19) · Glucose Metabolism Disorders (8) · Metabolic Diseases (8) · Hyperinsulinism (6) · Body Weight Changes (4) · Diabetes Mellitus (3) · Endocrine System Diseases (3) · Behavior (2)
Metformin (3) · Albuterol (2) · Qsymia (2) · semaglutide (2) · Acarbose (1) · Bariatric Surgery (1) · Cholecalciferol (1) · Exenatide (1) · Exergaming (1) · Inositol (1) · Iron-Dextran Complex (1) · Lactoferrin (1) · Lansoprazole (1) · Liraglutide (1) · Midazolam (1)
University of Milan (3) · Yale University (3) · Azienda Ospedaliero Universitaria Maggiore della Carita (2) · VIVUS LLC (2) · Ain Shams University (1) · Children's Hospital Medical Center, Cincinnati (1) · Children's Mercy Hospital Kansas City (1) · HÜMEYRA ACIKAN (1) · Loma Linda University (1) · Medical University of Vienna (1) · Ohio State University (1) · Signe Torekov (1) · UnitedHealth Group (1) · Universitas Indonesia (1) · University of Colombo (1)
United States (11) · Italy (5) · Brazil (1) · Canada (1) · Denmark (1) · Egypt (1) · Indonesia (1) · Sri Lanka (1) · Turkey (Türkiye) (1)
Tania S Burgert, MD (3) · Aaron Kelly, PhD (1) · Amy S Shah, MD MS (1) · Daniel Hsia, M.D. (1) · Dharini M Bhammar, MBBS, PhD (1) · Dharini M Bhammar, Ph.D. (1) · Elvira Verduci (1) · Jens-Christian Holm, Ass. Prof, PhD (1) · Jonathan M McGavock, PhD (1) · Kathryn Kyler, MD, MS (1) · Kristen J Nadeau, MD MS (1) · Louise Cominato, PI (1) · Marian GR Abdelsayed (1) · Michael A Helmrath, MD MS (1) · Natalia Bernardes, SI (1)
PMID 15482620, PMID 17850473, PMID 18761646, PMID 24522441, PMID 24589566, PMID 25376220, PMID 25774705, PMID 30156016, PMID 31146796, PMID 33544653, PMID 34229263, PMID 34389568, PMID 36968652, PMID 40518455, PMID 41501800
2019 (1), K23DK074439 (1), K23DK115827 (1)